These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

715 related articles for article (PubMed ID: 26859236)

  • 21. Effects of electroconvulsive therapy on serum levels of brain-derived neurotrophic factor and nerve growth factor in treatment resistant major depression.
    Bilgen AE; Bozkurt Zincir S; Zincir S; Ozdemir B; Ak M; Aydemir E; Sener I
    Brain Res Bull; 2014 May; 104():82-7. PubMed ID: 24747833
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of electroconvulsive therapy is associated with changing blood levels of homovanillic acid and brain-derived neurotrophic factor (BDNF) in refractory depressed patients: a pilot study.
    Okamoto T; Yoshimura R; Ikenouchi-Sugita A; Hori H; Umene-Nakano W; Inoue Y; Ueda N; Nakamura J
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jul; 32(5):1185-90. PubMed ID: 18403081
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rapid antidepressant effects of repeated doses of ketamine compared with electroconvulsive therapy in hospitalized patients with major depressive disorder.
    Ghasemi M; Kazemi MH; Yoosefi A; Ghasemi A; Paragomi P; Amini H; Afzali MH
    Psychiatry Res; 2014 Feb; 215(2):355-61. PubMed ID: 24374115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. BDNF serum levels and promoter methylation of BDNF exon I, IV and VI in depressed patients receiving electroconvulsive therapy.
    Kleimann A; Kotsiari A; Sperling W; Gröschl M; Heberlein A; Kahl KG; Hillemacher T; Bleich S; Kornhuber J; Frieling H
    J Neural Transm (Vienna); 2015 Jun; 122(6):925-8. PubMed ID: 25387785
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Repetitive transcranial magnetic stimulation is as effective as electroconvulsive therapy in the treatment of nondelusional major depressive disorder: an open study.
    Grunhaus L; Dannon PN; Schreiber S; Dolberg OH; Amiaz R; Ziv R; Lefkifker E
    Biol Psychiatry; 2000 Feb; 47(4):314-24. PubMed ID: 10686266
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BDNF, interleukin-6, and salivary cortisol levels in depressed patients treated with desvenlafaxine.
    Ninan PT; Shelton RC; Bao W; Guico-Pabia CJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan; 48():86-91. PubMed ID: 24096053
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does Physical Exercise Increase Brain-Derived Neurotrophic Factor in Major Depressive Disorder? A Meta-Analysis.
    Kurebayashi Y; Otaki J
    Psychiatr Danub; 2018 Jun; 30(2):129-135. PubMed ID: 29930221
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ECT seizure quality and serum BDNF, revisited.
    Sartorius A; Bumb JM; Aksay SS; Gass P; Hellweg R; Kranaster L
    Eur Arch Psychiatry Clin Neurosci; 2015 Jun; 265(4):359-60. PubMed ID: 25651974
    [No Abstract]   [Full Text] [Related]  

  • 29. [Acute and chronic effects of electroconvulsive therapy on neuroactive steroids in patients with major depressive disorder].
    Ozsoy S; Eşel E; Hacimusalar Y; Candan Z; Kula M; Turan T
    Turk Psikiyatri Derg; 2008; 19(4):341-8. PubMed ID: 19110975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Childhood trauma and platelet brain-derived neurotrophic factor (BDNF) after a three month follow-up in patients with major depressive disorder.
    Jeon HJ; Kang ES; Lee EH; Jeong EG; Jeon JR; Mischoulon D; Lee D
    J Psychiatr Res; 2012 Jul; 46(7):966-72. PubMed ID: 22551661
    [TBL] [Abstract][Full Text] [Related]  

  • 31. EFFICACY AND LONG-TERM CLINICAL OUTCOME OF COMORBID POSTTRAUMATIC STRESS DISORDER AND MAJOR DEPRESSIVE DISORDER AFTER ELECTROCONVULSIVE THERAPY.
    Ahmadi N; Moss L; Simon E; Nemeroff CB; Atre-Vaidya N
    Depress Anxiety; 2016 Jul; 33(7):640-7. PubMed ID: 26555786
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ketamine Anesthesia Does Not Improve Depression Scores in Electroconvulsive Therapy: A Randomized Clinical Trial.
    Carspecken CW; Borisovskaya A; Lan ST; Heller K; Buchholz J; Ruskin D; Rozet I
    J Neurosurg Anesthesiol; 2018 Oct; 30(4):305-313. PubMed ID: 29847468
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combining ECT with pharmacological treatment of depressed inpatients in a naturalistic study is not associated with serum BDNF level increase.
    Freire TF; Rocha NS; Fleck MP
    J Psychiatr Res; 2016 May; 76():30-7. PubMed ID: 26871734
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum BDNF as a peripheral biomarker of treatment-resistant depression and the rapid antidepressant response: A comparison of ketamine and ECT.
    Allen AP; Naughton M; Dowling J; Walsh A; Ismail F; Shorten G; Scott L; McLoughlin DM; Cryan JF; Dinan TG; Clarke G
    J Affect Disord; 2015 Nov; 186():306-11. PubMed ID: 26275358
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IL-1β and BDNF are associated with improvement in hypersomnia but not insomnia following exercise in major depressive disorder.
    Rethorst CD; Greer TL; Toups MS; Bernstein I; Carmody TJ; Trivedi MH
    Transl Psychiatry; 2015 Aug; 5(8):e611. PubMed ID: 26241349
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cognitive-behavioral therapy as continuation treatment to sustain response after electroconvulsive therapy in depression: a randomized controlled trial.
    Brakemeier EL; Merkl A; Wilbertz G; Quante A; Regen F; Bührsch N; van Hall F; Kischkel E; Danker-Hopfe H; Anghelescu I; Heuser I; Kathmann N; Bajbouj M
    Biol Psychiatry; 2014 Aug; 76(3):194-202. PubMed ID: 24462229
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship Between Hippocampal Volume, Serum BDNF, and Depression Severity Following Electroconvulsive Therapy in Late-Life Depression.
    Bouckaert F; Dols A; Emsell L; De Winter FL; Vansteelandt K; Claes L; Sunaert S; Stek M; Sienaert P; Vandenbulcke M
    Neuropsychopharmacology; 2016 Oct; 41(11):2741-8. PubMed ID: 27272769
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in interleukin-6 levels during electroconvulsive therapy may reflect the therapeutic response in major depression.
    Järventausta K; Sorri A; Kampman O; Björkqvist M; Tuohimaa K; Hämäläinen M; Moilanen E; Leinonen E; Peltola J; Lehtimäki K
    Acta Psychiatr Scand; 2017 Jan; 135(1):87-92. PubMed ID: 27858966
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum brain-derived neurotrophic factor (BDNF) is not associated with response to electroconvulsive therapy (ECT): a pilot study in drug resistant depressed patients.
    Fernandes B; Gama CS; Massuda R; Torres M; Camargo D; Kunz M; Belmonte-de-Abreu PS; Kapczinski F; de Almeida Fleck MP; Inês Lobato M
    Neurosci Lett; 2009 Apr; 453(3):195-8. PubMed ID: 19429034
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Electroconvulsive therapy suppresses the neurotoxic branch of the kynurenine pathway in treatment-resistant depressed patients.
    Schwieler L; Samuelsson M; Frye MA; Bhat M; Schuppe-Koistinen I; Jungholm O; Johansson AG; Landén M; Sellgren CM; Erhardt S
    J Neuroinflammation; 2016 Feb; 13(1):51. PubMed ID: 26925576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.